Related Experiment Video
Updated: Jun 13, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Natriuretic peptides in common valvular heart disease
Christopher D Steadman1, Simon Ray, Leong L Ng
1Department of Cardiovascular Sciences, University Hospitals of Leicester, Leicester, UK. cds18@le.ac.uk
Journal of the American College of Cardiology
|May 8, 2010
Summary
Natriuretic peptides show promise as biomarkers for valvular heart disease, correlating with severity and outcomes. Further studies are needed to confirm their clinical utility in aortic stenosis and mitral regurgitation management.
Area of Science:
- Cardiology
- Biomarkers
- Valvular Heart Disease
Background:
- Valvular heart disease, including aortic stenosis and mitral regurgitation, is prevalent and increasing.
- Management of asymptomatic patients with these conditions is challenging.
- Biomarkers are crucial in managing cardiovascular diseases like heart failure.
Purpose of the Study:
- To review the evidence for natriuretic peptides as biomarkers in aortic stenosis and mitral regurgitation.
- To assess the correlation of natriuretic peptides with disease severity and patient outcomes.
- To evaluate the potential clinical impact of natriuretic peptides in valvular heart disease.
Main Methods:
- Systematic review of current evidence.
- Analysis of studies investigating natriuretic peptides in valvular heart disease.
- Examination of correlations with disease severity, symptoms, and prognosis.
Main Results:
- Natriuretic peptides correlate with disease severity in aortic stenosis and mitral regurgitation.
- These peptides are associated with symptomatic status and predict patient outcomes.
- Evidence suggests potential utility in risk stratification and management.
Conclusions:
- Natriuretic peptides show significant promise as biomarkers for common valvular heart disease.
- Prospective studies are essential to determine the impact on clinical practice and patient outcomes.
- Routine clinical use requires further validation through rigorous research.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...